Litcius/Paper detail

Boron-ellagic acid hybrids as a molecular arrow: multi-targeted inhibition of AChE, anticancer activity, and antimicrobial action against MRSA and MDR E. coli, supported by docking analyses

Metin Yıldırım, Eyyup Yasar, Adem Necip, Mehmet Çimentepe, Gökhan Öztürk, Ahmet Kılıç

2025Journal of Molecular Liquids5 citationsDOI

Topics & Concepts

Ellagic acidChemistryAntimicrobialDocking (animal)Lead compoundProtein Data Bank (RCSB PDB)AntioxidantEnzymeBiological activityStereochemistryMechanism of actionBiochemistryCombinatorial chemistryIn vitroAntibacterial activityStructure–activity relationshipCytotoxicityCell cultureResidue (chemistry)Cancer cell linesIC50Cancer cellActive siteAlkaloidMolecular modelPharmacologyTriazoleReceptorPomegranate: compositions and health benefitsChemotherapy-induced cardiotoxicity and mitigationFerrocene Chemistry and Applications
Boron-ellagic acid hybrids as a molecular arrow: multi-targeted inhibition of AChE, anticancer activity, and antimicrobial action against MRSA and MDR E. coli, supported by docking analyses | Litcius